Impact of breast cancer on prospective memory functioning assessed by virtual reality and influence of sleep quality and hormonal therapy: PROSOM-K study
Mylène Duivon(Inserm), Bénédicte Giffard(Inserm), Grégory Lecouvey(Inserm), Jean‐Michel Grellard(Centre François Baclesse), Francis Eustache(Inserm), Idlir Licaj(La Ligue Contre le Cancer), Bénédicte Clarisse(Centre François Baclesse), Florence Fraisse(Inserm), Florence Joly(Inserm), Christelle Lévy(Centre François Baclesse), Philippe Fleury(Normandie Université), Fausto Viader(Inserm), Béatrice Desgranges(Inserm), Géraldine Rauchs(Inserm), Sophie Madeleine(Normandie Université), Joy Perrier(Inserm), Nicolas Lefèvre(Normandie Université)
Cited by 9
Related Papers
BRAF Inhibition in <i>BRAF</i> <sup>V600</sup> -Mutant Gliomas: Results From the VE-BASKET Study
|Journal of Clinical Oncology|2018|330
An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32)
|European Journal of Cancer|2005|241
An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer
|Nature Medicine|2021|115
Proton therapy for locally advanced breast cancer: A systematic review of the literature
|Cancer Treatment Reviews|2017|60
Cancer-related cognitive impairment: current perspectives on the management of cognitive changes following cancer treatment
|Expert Review of Neurotherapeutics|2023|31